SARS-CoV2/Rhinovirus interaction
Showing 1 - 25 of 9,279
Awake Prone Positioning in COVID-19 ICU Patients
Not yet recruiting
- SARS-CoV 2 Pneumonia
- quality of life questionnaire
-
Tours, Franceuniversity hospital Tours
Oct 10, 2023
Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination in
Not yet recruiting
- Systemic Sclerosis
- SARS-CoV 2 Vaccination
- (no location specified)
Jul 24, 2023
Covid19 Trial in Cypress (VXA-CoV2-1)
Completed
- Covid19
- VXA-CoV2-1
-
Cypress, CaliforniaWCCT
Jan 17, 2023
SARS-CoV2 Infection Trial in Flint (General SARS-CoV-2 Communication, Rural-Targeted SARS-CoV-2 Communication)
Recruiting
- SARS-CoV2 Infection
- General SARS-CoV-2 Communication
- Rural-Targeted SARS-CoV-2 Communication
-
Flint, MichiganFlint Journal Building
Oct 10, 2023
SARS-CoV-2 Virus Trial in Bangkok (SARS-CoV-2 RNA detection)
Completed
- SARS-CoV-2 Virus
- SARS-CoV-2 RNA detection
-
Bangkok, Thailand2 Division of Nephrology,Department of Medicine Pramongkutklao H
Aug 31, 2023
SARS-CoV-2 Trial in Nanjing (SARS-CoV-2 Bivalent mRNA Vaccine, Recombinant SARS-CoV-2 vaccine, Saline)
Not yet recruiting
- SARS-CoV-2
- SARS-CoV-2 Bivalent mRNA Vaccine
- +2 more
-
Nanjing, Jiangsu, ChinaJiangsu Provincial Center for Disease Control and Prevention
Jul 7, 2023
SARS-CoV-2 Infection, Varicella, Measles Trial in Shanghai (Inactivated SARS-CoV-2 vaccine coadministered with vricella vaccine,
Not yet recruiting
- SARS-CoV-2 Infection
- +4 more
- Inactivated SARS-CoV-2 vaccine coadministered with vricella vaccine
- +2 more
-
Shanghai, Shanghai, ChinaShanghai Municipal Center for Disease Control and Prevention
Jul 17, 2023
a Randomized Double-blind Study, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), PHYTOTHERAPIE Trial in Sahloul
Completed
- a Randomized Double-blind Study
- +2 more
-
Sahloul, Sousse, TunisiaRiadh Boukef
Jan 2, 2023
SARS-CoV-2 Trial in Nanjing (SARS-CoV-2 Bivalent mRNA Vaccine, Saline)
Not yet recruiting
- SARS-CoV-2
- SARS-CoV-2 Bivalent mRNA Vaccine
- Saline
-
Nanjing, Jiangsu, ChinaJiangsu Provincial Center for Disease Control and Prevention
Jul 7, 2023
SARS-COV2 Pandemic Serosurvey in a Rare Disease Population
Completed
- SARS-COV2 Virus
-
Bethesda, Maryland
- +1 more
Dec 16, 2022
SARS-CoV-2 Trial in Chengdu (SARS-CoV-2 mRNA vaccine (RBMRNA), CoronaVac®)
Active, not recruiting
- SARS-CoV-2
- SARS-CoV-2 mRNA vaccine (RBMRNA)
- CoronaVac®
-
Chengdu, Sichuan, ChinaChengdu Xinhua Hospital affiliated to North Sichuan Medical Coll
Jun 12, 2023
LumiraDX SARS-CoV-2 Ag Ultra and LumiraDX SARS-CoV-2 & Flu A/B
Not yet recruiting
- SARS-CoV-2
- +4 more
- LumiraDx SARS-CoV-2 Ag Ultra
- LumiraDx SARS-CoV-2 & Flu A/B
-
DeLand, FloridaHillcrest Medical Research
Feb 6, 2023
COVID-19 Trial (NVX-CoV2601 co-formulated Omicron XBB.1.5 SARS-CoV-2 rS vaccine, Prototype/XBB.1.5 Bivalent Vaccine (5 µg))
Not yet recruiting
- COVID-19
- NVX-CoV2601 co-formulated Omicron XBB.1.5 SARS-CoV-2 rS vaccine
- Prototype/XBB.1.5 Bivalent Vaccine (5 µg)
- (no location specified)
Aug 4, 2023
Viral Dynamics of Omicron in Children
Completed
- SARS-CoV2 Infection, COVID-19
- Daily SARS-CoV-2 PCR Testing for 10 days
-
Toronto, Ontario, CanadaThe Hospital for Sick Children
Nov 25, 2022
SARS-CoV-2 Vaccination on Cancer Patients Infected With
Recruiting
- COVID-19 Infection
- COVID-19 Vaccine
- no intervention
-
Beijing, Beijing, ChinaSanhuan Cancer Hospital, Chaoyang District, Beijing(Cancer Hospi
Mar 7, 2023
Zinc Deficiency, Sars-CoV-2 Infection Trial in Barcelona (Zinc Acetate)
Completed
- Zinc Deficiency
- Sars-CoV-2 Infection
- Zinc Acetate
-
Barcelona, SpainHospital del Mar
Mar 18, 2023
SARS-CoV-2 Trial in Islamabad (SARS-CoV-2 Bivalent mRNA vaccine (LVRNA021), 0.9% sodium chloride solution)
Recruiting
- SARS-CoV-2
- SARS-CoV-2 Bivalent mRNA vaccine (LVRNA021)
- 0.9% sodium chloride solution
-
Islamabad, PakistanSindh Infectious Diseases Hospital & Research Center Dow Univers
Apr 16, 2023
COVID-19 Trial in Guangzhou (the recombinant SARS-CoV-2 S-Trimer vaccine/inactivated SARS-CoV-2 vaccine)
Recruiting
- COVID-19
- the recombinant SARS-CoV-2 S-Trimer vaccine/inactivated SARS-CoV-2 vaccine
-
Guangzhou, Guangzhou, ChinaThe Fifth Affiliated Hospital of Guangzhou Medical University
Jan 28, 2023
Immunogenicity, Safety Trial (Phase II:SWIM816;SARS-Cov-2;, Phase II:SW-BIC-213;SARS-Cov-2;, PhaseIII:SWIM816;SARS-Cov-2;)
Not yet recruiting
- Immunogenicity
- Safety
- Phase II:SWIM816;SARS-Cov-2;
- +3 more
- (no location specified)
Jun 18, 2023
Lipids in SARS-CoV2 Infection - In Search of Atherogenic
Recruiting
- SARS-CoV2 Infection
- Blood sample of 30 ml
-
Dijon, FranceChu Dijon Bourgogne
Jul 25, 2022
Vitamin D and Vitamin D Binding Protein With Disease Severity in
Active, not recruiting
- SARS CoV-2 Infection
- Vitamin D Binding protein
-
Istanbul, TurkeyHaseki Training and Research Hospital
Nov 1, 2022
SARS-CoV-2 Infection, COVID-19, Coronavirus Trial in Marseille, Nîmes (eBAM Cov Testing)
Not yet recruiting
- SARS-CoV-2 Infection
- +2 more
- eBAM Cov Testing
-
Marseille, France
- +1 more
Oct 23, 2023
Respiratory Viral Infection Trial (SARS-COV-2, Influenza and RSV 8-Well MT-PCR Panel, BioFire Respiratory Panel 2.1)
Not yet recruiting
- Respiratory Viral Infection
- SARS-COV-2, Influenza and RSV 8-Well MT-PCR Panel
- BioFire Respiratory Panel 2.1
- (no location specified)
Jul 13, 2023
Sars-Covid-19 Vaccines in Haematological Patients: Prospective
Completed
- Hematologic Diseases
- IgG antibodies to Sars-Cov-2
- QuantiFERON SARS-CoV-2 test
-
Monza, Lombardia, ItalySan Gerardo Hospital
Jan 23, 2023
Influenza A, Influenza Type B, SARS CoV 2 Infection Trial in Raleigh (Diagnostic Test for identification of influenzas A,
Not yet recruiting
- Influenza A
- +3 more
- Diagnostic Test for identification of influenzas A, influenzas B, RSV and SARS-CoV-2 infections
-
Raleigh, North CarolinaWake Med
Jun 26, 2023